ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

INBX Inhibrx Inc

34,15
0,14 (0,41%)
03 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Inhibrx Inc INBX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,14 0,41% 34,15 23:22:21
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
34,35 33,87 34,45 34,15 34,01
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
11.3.202421:26EDGAR2Form 144 - Report of proposed sale of securities
08.3.202422:08EDGAR2Form 144 - Report of proposed sale of securities
08.3.202421:28EDGAR2Form 144 - Report of proposed sale of securities
06.3.202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202420:58EDGAR2Form 144 - Report of proposed sale of securities
05.3.202400:26EDGAR2Form 144 - Report of proposed sale of securities
29.2.202423:26EDGAR2Form PREM14A - Preliminary proxy statements relating to..
28.2.202415:15PRNUSInhibrx Reports Fourth Quarter and Fiscal Year 2023..
28.2.202415:12EDGAR2Form 8-K - Current report
28.2.202415:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
14.2.202422:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06.2.202422:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
26.1.202418:12PRNUSKuehn Law Encourages DOC, BATL, KAMN, and INBX Investors to..
23.1.202423:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23.1.202412:38EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23.1.202412:35EDGAR2Form 8-K - Current report
23.1.202412:05DJNSanofi to Buy Assets From Inhibrx in Deal Valued at Up to..
23.1.202411:40IHMARKETNEWSWall Street Highlights: Vroom Shuts Down Online Car Sales,..
23.1.202407:00PRNUSInhibrx Announces Sale of INBRX-101 to Sanofi for an..
09.11.202322:03EDGAR2Form 8-K - Current report
09.11.202322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.11.202322:00PRNUSInhibrx Reports Third Quarter 2023 Financial Results and..
02.11.202314:16EDGAR2Form 8-K - Current report
02.11.202314:15PRNUSInhibrx Announces Preliminary Data from the Phase 1 Trial of..
18.10.202322:00PRNUSInhibrx Announces Participation in Upcoming Scientific..
19.9.202322:03EDGAR2Form 8-K - Current report
19.9.202322:00PRNUSInhibrx Retains Rights to INBRX-101 for the Treatment of..
31.8.202322:06EDGAR2Form D - Notice of Exempt Offering of Securities
29.8.202315:03EDGAR2Form 8-K - Current report
29.8.202315:00PRNUSInhibrx Announces $200 Million Private Placement Financing
07.8.202322:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.8.202322:00PRNUSInhibrx Reports Second Quarter 2023 Financial Results and..
30.5.202315:46DJNInhibrx Granted FDA Fast Track Designation for INBRX-101
30.5.202315:00PRNUSInhibrx Granted Fast Track Designation for INBRX-101 for the..
08.5.202322:05PRNUSInhibrx Reports First Quarter 2023 Financial Results and..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock